Dense Deposit Disease (DDD)
1 clinical trials · Condition
◉ Watch Dense Deposit Disease (DDD)
| Record | Firm | Date |
|---|---|---|
| Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN (NCT04572854) | Apellis Pharmaceuticals, Inc. | 2021-09-07 |
Track Dense Deposit Disease (DDD) automatically
Every clearance here is in the API, with alerts when new ones post.